{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiejbpezcgopcf2qboi5vrylak4zoqfovv2j2hznigj62crlgeoi44",
    "uri": "at://did:plc:ixaay4mtxw5lj4a457vohlrr/app.bsky.feed.post/3mk7ikoee4ml2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib6r2m46mz3nxrblfmowrz2zlz56omi2d4lamd4vixv7b6n7fv4im"
    },
    "mimeType": "image/jpeg",
    "size": 49612
  },
  "path": "/politics/2026/04/23/trump-strikes-deal-with-regeneron-marking-17th-major-pharmaceutical-deal-since-fall/",
  "publishedAt": "2026-04-23T23:46:16.000Z",
  "site": "https://www.breitbart.com",
  "tags": [
    "Health",
    "Politics",
    "America First",
    "Donald Trump",
    "drug prices",
    "Howard Lutnick",
    "Medicaid",
    "Pfizer",
    "pharmaceuticals",
    "Regeneron",
    "Robert F. Kennedy Jr.",
    "TrumpRx",
    "Trump Strikes Deal with Regeneron Marking 17th Major Pharmaceutical Deal Since Fall",
    "Breitbart"
  ],
  "textContent": "WASHINGTON—President Donald Trump announced a deal to bring state Medicaid programs access to most-favored-nation pricing on new Regeneron drugs, marking the 17th deal he has struck with a major pharmaceutical company since the fall.\n\nThe post Trump Strikes Deal with Regeneron Marking 17th Major Pharmaceutical Deal Since Fall appeared first on Breitbart.",
  "title": "Trump Strikes Deal with Regeneron Marking 17th Major Pharmaceutical Deal Since Fall"
}